Abstract
Background/Aims: In addition to affective and cognitive symptomatology, psychomotor deficits are known to be present in bipolar disorder (BD). Psychomotor functioning includes all of the processes necessary for completing a movement, from planning to initiation and execution. While these psychomotor symptoms have been studied extensively in schizophrenia and major depressive disorder, only simple measures have been conducted in BD. The present study examines psychomotor functioning in BD. Methods: Twenty-two euthymic BD patients and 21 healthy controls performed three computerized copying tasks varying in cognitive load. Movement times (MT), reflecting fine motor processing, and initiation times (IT), reflecting cognitive processing of visual-spatial information, were separately measured in each group. Results: The BD patients had longer IT but not MT in the simplest task and the opposite pattern of longer MT but not IT in the complex task. However, when controlling for residual mood symptoms, the MT were no longer significantly slower in the BD group. Conclusions: The longer MT and IT in BD reflect overall psychomotor slowing. Specifically, the results provide evidence for cognitive slowing in BD. In addition, the longer MT in the complex task reflect a slowed motor component of movement when the cognitive load is high and when depressive symptoms are present. These findings extend the current knowledge of the nature of psychomotor slowing in BD and may have important prognostic implications for patients.
References
1.
Bearden CE, Hoffman KM, Cannon TD: The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001;3:106-150.
2.
Burdick KE, Gunawardane N, Goldberg JF, Halperin JM, Garno JL, Malhotra AK: Attention and psychomotor functioning in bipolar depression. Psychiatry Res 2009;166:192-200.
3.
Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P: Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007;9:114-125.
4.
Arts B, Jabben N, Krabbendam L, Van Os J: Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008;38:771-785.
5.
Bora E, Yucel M, Pantelis C: Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009;113:1-20.
6.
Morrens M, Hulstijn W, Matton C, Madani Y, van Bouwel L, Peuskens J, Sabbe B: Delineating psychomotor slowing from reduced processing speed in schizophrenia. Cogn Neuropsychiatry 2008a;13:457-471.
7.
Morrens M, Hulstijn W, Van Hecke J, Peuskens J, Sabbe B: Sensorimotor and cognitive slowing in schizophrenia as measured by the Symbol Digit Substitution Test. J Psychiatr Res 2006;40:200-206.
8.
Lezak D: Neuropsychological Assessment, ed 2. New York, Oxford University Press, 1993.
9.
Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
10.
Kalra L, Jackson SH, Swift CG: Psychomotor performance in elderly hypertensive patients. J Hum Hypertens 1993;7:279-284.
11.
Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ: Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001;102:9-20.
12.
Varga M, Magnusson A, Flekkøy K, Rønneberg U, Opjordsmoen S: Insight, symptoms and neurocognition in bipolar I patients. J Affect Disord 2006;91:1-9.
13.
Pier MPBI, Hulstijn W, Sabbe BGC: Psychomotor retardation in elderly depressed patients. J Affect Disord 2004a;81:73-77.
14.
Sabbe B, Hulstijn W, van Hoof J, Tuynmn-Quq HG, Zitman F: Retardation in depression: assessment by means of simple motor tasks. J Affect Disord 1999;55:39-44.
15.
Sabbe B, Hulstijn W, Van Hoof J, Zitman F: Fine motor retardation and depression. J Psychiatr Res 1996;30:295-306.
16.
Schrijvers D, de Bruijn ERA, Maas Y, De Grave C, Sabbe BCG, Hulstijn W: Action monitoring in major depressive disorder with psychomotor retardation. Cortex 2008a;44:569-579.
17.
Pieters G, Hulstijn W, Maas Y, Vandereycken W, Peuskens J, Probst M, Sabbe B: Psychomotor performance and sequence planning in anorexia nervosa before and after weight restoration. Eat Weight Disord 2006;11:154-162.
18.
Pieters G, Sabbe B, Hulstijn W, Probst M, Vandereycken W, Peuskens J: Fast psychomotor functioning in underweight anorexia nervosa patients. J Psychiatr Res 2003;37:501-508.
19.
De Wilde B, Dom G, Hulsijn W, Sabbe B: Motor functioning and alcohol dependence. Alcohol Clin Exp Res 2007;31:1820-1825.
20.
Jogems-Kosterman B, Hulstijn W, Wezenberg E, van Hoof J: Movement planning deficits in schizophrenia: failure to inhibit automatic response tendencies. Cogn Neuropsychiatry 2006;11:47-64.
21.
Jogems-Kosterman BJM, Zitman FG, Van Hoof JJM, Hulstijn W: Psychomotor slowing and planning deficits in schizophrenia. Schizophr Res 2001;48:317-333.
22.
Schrijvers D, Hulsijn W, Sabbe BGC: Psychomotor symptoms in depression: a diagnostic, pathophysiological and therapeutic tool. J Affect Disord 2008b;109:1-20.
23.
Morrens M, Hulstijn W, Sabbe B: Psychomotor slowing in schizophrenia. Schizophr Bull 2007;33:1038-1053.
24.
Morrens M, Hulstijn W, Lewi P, Sabbe B: Bleuler revisited. Psychomotor slowing in schizophrenia as part of a catatonic symptom cluster. Psychiatry Res 2008b;161:121-125.
25.
Van Hoof JJM, Jogems-Kosterman BJM, Sabbe BGC, Zitman FG Hulstijn W: Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia. J Psychiatr Res 1998;32:99-103.
26.
Jogems-Kosterman BJ: Psychomotor slowing and planning deficits in schizophrenia; thesis, Catholic University of Nijmegen, Nijmegen, 2004, pp 89-144.
27.
Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
28.
Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435.
29.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
30.
Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, Benebarre A, Goikolea JM, Comes M, Salamero M: Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262-270.
31.
Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, Young AH: Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005;186:32-40.
32.
Ferrier IN, Stanton BR, Kelly TP, Scott J: Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999;175:246-251.
33.
Caligiuri MP, Ellwanger J: Motor and cognitive aspects of motor retardation in depression. J Affect Disord 2000;57:83-93.
34.
Iverson GL: Objective assessment of psychomotor retardation in primary care patients with depression. J Behav Med 2004;27:31-37.
35.
Brébion G, Smith MJ, Widlocher D: Discrimination and response bias in memory: effects of depression severity and psychomotor retardation. Psychiatry Res 1997;70:95-103.
36.
Lemke MR, Puhl P, Koethe N, Winkler T: Psychomotor retardation and anhedonia in depression. Acta Psychiatr Scand 1999;99:252-256.
37.
Goswami U, Sharma A, Khastigir U, Ferrier IN, Young AH, Gallagher P, et al: Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry 2006;188:366-373.
38.
Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988;145:11-18.
39.
Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004;72:41-51.
40.
Gazzaniga S, Ivry RB, Mangun GR: Cognitive Neuroscience: The Biology of the Mind, ed 4. New York, WW Norton, 2014.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
